Zhenkui Pan

发表

PD‐(L)1 inhibitors vs. chemotherapy vs. their combination in front‐line treatment for NSCLC: An indirect comparison

W. Liang, Jianxing He, Hengrui Liang, 2019, International journal of cancer.

S-1-based versus 5-FU-based chemotherapy as first-line treatment in advanced gastric cancer: a meta-analysis of randomized controlled trials

H. An, Jingxun Wu, Zhenkui Pan, 2014, Tumor Biology.

PD-L1 expression with respect to driver mutations in non-small cell lung cancer in an Asian population: a large study of 1370 cases in China

W. Liang, Jianxing He, Hengrui Liang, 2020, Therapeutic advances in medical oncology.

The incidence of lymph node metastasis in patients with different oncogenic driver mutations among T1 non-small-cell lung cancer.

W. Liang, Jianxing He, Hengrui Liang, 2019, Lung cancer.

Association between certain non–small cell lung cancer driver mutations and predictive markers for chemotherapy or programmed death‐ligand 1 inhibition

W. Liang, Jianxing He, P. He, 2019, Cancer science.

The alteration of T790M between 19 del and L858R in NSCLC in the course of EGFR-TKIs therapy: a literature-based pooled analysis.

W. Liang, Jianxing He, Hengrui Liang, 2018, Journal of thoracic disease.

Efficacy and safety of first line treatments for patients with advanced epidermal growth factor receptor mutated, non-small cell lung cancer: systematic review and network meta-analysis

Jun Liu, W. Liang, Jianxing He, 2019, British medical journal.

Profiling Tumor Immune Microenvironment of Non-Small Cell Lung Cancer Using Multiplex Immunofluorescence

Tao Yu, W. Liang, Jianxing He, 2021, bioRxiv.

Clinicopathological and prognostic significance of programmed cell death ligand1 (PD-L1) expression in patients with non-small cell lung cancer: a meta-analysis.

H. An, Jingxun Wu, Zhenkui Pan, 2015, Journal of thoracic disease.

[Epidermal growth factor receptor mutation in Chinese patients with non-small cell lung cancer].

Jian-hua Chang, Z. Guan, Ning Li, 2005, Ai zheng = Aizheng = Chinese journal of cancer.

[K-RAS gene mutations in patients with non-small cell lung cancer].

Yang Zhang, Li Zhang, Xing Zhang, 2010, Zhongguo fei ai za zhi = Chinese journal of lung cancer.

Development and validation of a deep transfer learning-based multivariable survival model to predict overall survival in lung cancer

W. Liang, Caichen Li, Jianfu Li, 2023, Translational lung cancer research.

The impact of epidermal growth factor receptor mutations on the prognosis of resected non-small cell lung cancer: a meta-analysis of literatures.

W. Liang, Jianxing He, Qi-hua He, 2019, Translational lung cancer research.

The association between human papillomavirus presence and epidermal growth factor receptor mutations in Asian patients with non-small cell lung cancer.

W. Liang, Hengrui Liang, Wei Wang, 2018, Translational lung cancer research.